OMNY Health has launched an AI-powered platform for health technology companies to leverage its operational data on over 75 million patients. Two companies, QuantHealth and ArisGlobal, are the first to utilize this data. QuantHealth will use the data to improve clinical trial design and predict outcomes, while ArisGlobal will focus on drug development and safety monitoring. OMNY’s goal is to make data more accessible for research and development in healthcare. Overall, this partnership aims to accelerate breakthrough therapies and improve patient care. Other collaborations with Datavant and funding for QuantHealth show a growing trend in leveraging data for healthcare advancements.
Source link